Pages that link to "Q36966660"

The following pages link to Amyloid-β peptide: Dr. Jekyll or Mr. Hyde? (Q36966660):

Displaying 36 items.

• Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy (Q26382049) (← links)
• Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT (Q26749755) (← links)
• Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression (Q26765559) (← links)
• Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics (Q26822002) (← links)
• "Is dopamine involved in Alzheimer's disease?" (Q26851680) (← links)
• Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease (Q27003841) (← links)
• Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model (Q27316689) (← links)
• Nicotinic ACh receptors as therapeutic targets in CNS disorders (Q28111941) (← links)
• An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice (Q30316057) (← links)
• Characterization of a single-chain variable fragment recognizing a linear epitope of aβ: a biotechnical tool for studies on Alzheimer's disease? (Q34652305) (← links)
• Synaptic therapy in Alzheimer's disease: a CREB-centric approach (Q35064948) (← links)
• Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease? (Q35969643) (← links)
• Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease (Q35974488) (← links)
• The keystone of Alzheimer pathogenesis might be sought in Aβ physiology (Q36113757) (← links)
• Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin (Q36319298) (← links)
• Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity (Q36489274) (← links)
• APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses (Q36585916) (← links)
• PP2A methylation controls sensitivity and resistance to β-amyloid-induced cognitive and electrophysiological impairments (Q36742759) (← links)
• Seizure-Induced Regulations of Amyloid-β, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity. (Q36809843) (← links)
• The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. (Q38094984) (← links)
• The potential role of rho GTPases in Alzheimer's disease pathogenesis (Q38180966) (← links)
• The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease (Q38281324) (← links)
• Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory (Q38720261) (← links)
• Haptoglobin modulates beta-amyloid uptake by U-87 MG astrocyte cell line (Q38939828) (← links)
• Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein (Q41026207) (← links)
• In Vivo Sub-chronic Treatment with Dichlorvos in Young Rats Promotes Synaptic Plasticity and Learning by a Mechanism that Involves Acylpeptide Hydrolase Instead of Acetylcholinesterase Inhibition. Correlation with Endogenous β-Amyloid Levels. (Q41109282) (← links)
• Oxidative stress and the amyloid beta peptide in Alzheimer's disease (Q46272723) (← links)
• Structural and functional analyses of pyroglutamate-amyloid-β-specific antibodies as a basis for Alzheimer immunotherapy (Q46348872) (← links)
• Impact of amyloid-beta changes on cognitive outcomes in Alzheimer's disease: analysis of clinical trials using a quantitative systems pharmacology model. (Q48113629) (← links)
• Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism. (Q55007427) (← links)
• The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease. (Q55411317) (← links)
• Passive Aβ Immunotherapy: Current Achievements and Future Perspectives (Q60530538) (← links)
• Acetylation of Aβ42 at Lysine 16 Disrupts Amyloid Formation (Q90620606) (← links)
• A Role for Drosophila Amyloid Precursor Protein in Retrograde Trafficking of L1-Type Cell Adhesion Molecule Neuroglian (Q92237683) (← links)
• Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts (Q92402680) (← links)
• Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer's Disease Progression (Q92856555) (← links)